Betaserc Betahistine 24mg Vertigo & Meniere's Disease Relief Tablets 60s

• Betahistine dihydrochloride 24mg tablets – 60-tablet pack • First-line treatment for Ménière’s disease and vestibular vertigo • Improves inner-ear microcirculation and reduces endolymphatic pressure • Standard dose: 48mg/day (2 tablets daily) – convenient twice-daily regimen • Suitable for adults with vertigo, tinnitus, and hearing loss caused by inner-ear disorders • Film-coated tablets – easy to swallow, minimal gastric irritation • Prescription medicine – well-established safety profile since 1970

Betaserc 24mg (betahistine) is a histamine analogue that acts as a vasodilator in the inner ear and modulates vestibular system neurotransmission. Clinically proven to reduce the frequency and severity of vertigo attacks in Ménière’s disease by 60–80% and significantly improve associated tinnitus and hearing fluctuation. Rapid onset (within days) with maximum effect in 2–4 weeks. Excellent long-term tolerability – can be used continuously for years. Benefits • Reduces vertigo episodes by up to 80% in Ménière’s patients • Decreases intensity & duration of dizziness spells • Improves associated tinnitus & feeling of ear fullness • Twice-daily dosing (morning & evening) – high compliance • Non-sedating – does not cause drowsiness like some anti-vertigo drugs • Safe for elderly & long-term use • Low incidence of side effects (mainly mild gastric upset) How to Use • Usual dose: 1 tablet (24mg) twice daily (total 48mg/day) • Take with or after food to reduce stomach irritation • Swallow whole with water – do not crush or chew • Continue treatment for several months (minimum 2–3 months) • Improvement may take 2–4 weeks; do not stop abruptly • Missed dose: take as soon as remembered unless near next dose • Store below 25°C in original packaging